PharmARC has expertise in clinical trial landscape, pipeline analysis, company analysis, daily/weekly/monthly/quarterly reports, conference CI, ad-hoc analysis, and CI database applications/portals.

We support brand teams in various therapy areas through ad-hoc or ongoing FTE-based engagements. The on-shore/off-shore support through continuous engagement ensures a smooth transition of processes and execution in an extremely cost-effective manner. This helps the brand teams in analyzing KITs and KIQs, enabling effective decision-making.

Our expertise in secondary desk research includes collection, synthesis, and analysis through sources such as Scrip World Pharmaceutical News, The Pink Sheet, Medscape, BMJ, NEJM, Lancet, JAMA, FDA Website, EMEA Website, Clinical Trials.gov, Cancer.gov (National Cancer Institute), FirstWord and other portals. Additionally, we have experience in analyzing information from databases such as IDdb3, Adis Insights, CD Promo, Datamonitor, Decision Resources, IMS, Factiva, Trial Trove, Espicom, Biomedical News Analyzer, Pharma Projects, Pharma Pipelines, Reuters Knowledge Link, Onesource, and other such client provided sources.

We are a member of SCIP and follow the Code of Ethics for Competitive Intelligence laid out by SCIP.